GSK3987
CAS No. 264206-85-1
GSK3987 ( —— )
产品货号. M27880 CAS No. 264206-85-1
GSK3987 is an LXR ligand. GSK3987 recruits the steroid receptor coactivator-1 to human LXRalpha and LXRbeta with EC50s of 40 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2066 | 有现货 |
|
10MG | ¥3345 | 有现货 |
|
25MG | ¥5605 | 有现货 |
|
50MG | ¥7979 | 有现货 |
|
100MG | ¥10773 | 有现货 |
|
500MG | ¥21546 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK3987
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK3987 is an LXR ligand. GSK3987 recruits the steroid receptor coactivator-1 to human LXRalpha and LXRbeta with EC50s of 40 nM.
-
产品描述GSK3987 is an LXR ligand. GSK3987 recruits the steroid receptor coactivator-1 to human LXRalpha and LXRbeta with EC50s of 40 nM.(In Vitro):In primary human macrophages, GSK3987 (30, 100, 300, 1000 nM) increased the expression of ABCA1 and induces cellular cholesterol efflux to apoA1 particles in a dose-dependent manner. In human hepatoma (HepG2) cells, GSK3987 (6-1500 nM) increases the expression of SREBP-1c and induces triglyceride accumulation in a dose-dependent manner. GSK3987 showed activity with EC50s of 0.08 μM, 50 nM, 40 nM for ABCA1, LXRα-SRC1, LXRβ-SRC1, respectively.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体EP4
-
研究领域——
-
适应症——
化学信息
-
CAS Number264206-85-1
-
分子量384.4
-
分子式C24H20N2O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCOc1ccc(NC2=C(C(=O)N(Cc3ccccc3)C2=O)c2ccccc2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yang JJ,?et al. Discovery and Characterization of 1H-1,2,3-Triazole Derivatives as Novel Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy. J Med Chem.?2020 Jan 23;63(2):569-590.
产品手册
关联产品
-
KHK-IN-1
KHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.
-
Isovitexin-2-O-rhamn...
Isovitexin-2''-O-rhamnoside has a role as an antifeedant and a plant metabolite.Antioxidant activities.Anti-hepatotoxic activities.
-
NPT200-11
NPT200-11 is an orally bioavailable and brain penetrating inhibitor of accumulation of alpha-synuclein (ASYN) misfolding and aggregation.